Literature DB >> 19261412

The hearing status in 12 female and 15 male Japanese Fabry patients.

Yuika Sakurai1, Hiromi Kojima, Masanori Shiwa, Toya Ohashi, Yoshikatsu Eto, Hiroshi Moriyama.   

Abstract

OBJECTIVE: Fabry disease (FD) is an x-linked inherited disease that causes a lack of a lysosomal enzyme, alpha-galactosidaseA, leading to cellular accumulation of glycosphingolipids of the whole body. This accumulation in the inner ear causes hearing loss also. However, FD is rare, and the frequency is lower in females than in males. Thus, there have been few comparative studies between women and men for hearing loss in FD. Accordingly, we examined the hearing status of both male and female FD patients and elucidated the similarities and differences. We also analyzed for correlations between the hearing status and renal and heart disorders.
METHODS: 12 women and 15 men were studied by means of pure tone audiometry, the relationships between the hearing status and the renal and cardiac functions.
RESULTS: The audiogram type was the flat type in a majority of both women and men, followed by the high type and low type, while the U-shaped type was rare. Examination of the thresholds average showed abnormality in one woman and four men. Comparison to threshold for each age bracket of normal subjects showed abnormality in three women and nine men. No correlations were found between the hearing loss and either the renal or cardiac function. All the patients with renal dysfunction had abnormal hearing.
CONCLUSIONS: The frequency of hearing loss in FD was higher in men than in women. Also, there may be some relationship between renal function and hearing loss in FD.

Entities:  

Mesh:

Year:  2009        PMID: 19261412     DOI: 10.1016/j.anl.2009.01.001

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  7 in total

1.  Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.

Authors:  Eefje B Suntjens; Bouwien E Smid; Marieke Biegstraaten; Wouter A Dreschler; Carla E M Hollak; Gabor E Linthorst
Journal:  J Inherit Metab Dis       Date:  2014-11-14       Impact factor: 4.982

Review 2.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

3.  Otological aspects of Fabry disease in patients with normal hearing.

Authors:  Fei Wang; Hiroshi Yamamoto; Tadao Yoshida; Satofumi Sugimoto; Masaaki Teranishi; Kazuya Tsuboi; Michihiko Sone
Journal:  Nagoya J Med Sci       Date:  2019-08       Impact factor: 1.131

4.  Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment.

Authors:  Puriya Daniel Yazdanfard; Christoffer Valdorff Madsen; Lars Holme Nielsen; Åse Krogh Rasmussen; Jørgen Holm Petersen; Alka Seth; Søren Schwartz Sørensen; Lars Køber; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2019-12-06       Impact factor: 3.240

Review 5.  Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.

Authors:  Fatih Ezgu; Erkan Alpsoy; Zerrin Bicik Bahcebasi; Ozgur Kasapcopur; Melis Palamar; Huseyin Onay; Binnaz Handan Ozdemir; Mehmet Akif Topcuoglu; Omac Tufekcioglu
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

6.  Long-term effect of enzyme replacement therapy with fabry disease.

Authors:  Manabu Komori; Yuika Sakurai; Hiromi Kojima; Toya Ohashi; Hiroshi Moriyama
Journal:  Int J Otolaryngol       Date:  2013-10-08

7.  Hearing loss in children with Fabry disease.

Authors:  E Suntjens; W A Dreschler; J Hess-Erga; R Skrunes; F A Wijburg; G E Linthorst; C Tøndel; M Biegstraaten
Journal:  J Inherit Metab Dis       Date:  2017-05-31       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.